European multidisciplinary guideline for tinnitus

Record details

• Authors: Cima RFF, Mazurek B, Haider H, et al.
• Journal / source: HNO (2019)
• Design: Clinical practice guideline (Europe)
• Sample: Multinational guideline
• Primary endpoint: —
• Randomized: No · Sham/placebo-controlled: No · Independent of the manufacturer: Yes

What this research found

CBT: STRONG recommendation FOR. Hearing aids: FOR, with hearing loss. Sound therapy: recommendation for RESEARCH only (no practice recommendation — not an 'against'). Pharmacotherapy: weak recommendation AGAINST. Transcranial electrical stimulation: AGAINST.

Stances verified via a peer-reviewed secondary source (Langguth et al., J Clin Med 2023, PMC10178961) because the primary full text is paywalled; verbatim wording and grading system therefore marked unable-to-verify. Together with AAO-HNSF 2014 and NICE NG155, the three guidelines agree on CBT (for) and drugs (against) and diverge on sound therapy.

Limitations and conflicts of interest

Verbatim wording not independently verified (see detail).

Funding / conflicts: Professional societies.

Primary sources

• PubMed record (30847513)
• Publisher (DOI 10.1007/s00106-019-0633-7)
• Source link

Used as evidence for

• Cognitive Behavioral Therapy (CBT)
• Hearing aids (with hearing loss)
• Sound therapy & masking